The effect of green tea on patients with type 2 diabetes mellitus: A meta-analysis
The effect of green tea on patients with type 2 diabetes mellitus: A meta-analysis
Jia et al., 2024 | Medicine (Baltimore) | Meta Analysis
Citation
Jia Ming-Jie, Liu Xing-Ning, ... Li Hui-Lin. The effect of green tea on patients with type 2 diabetes mellitus: A meta-analysis. Medicine (Baltimore). 2024-Nov-22;103(47):e39702. doi:10.1097/MD.0000000000039702
Abstract
BACKGROUND: To systematically evaluate the effect of green tea on patients with type 2 diabetes. METHODS: A computer search Cochrane, PubMed, Embase, CNKI, Wanfang, VIP, and other Chinese and English databases were conducted for randomized controlled trials of green tea in the treatment of patients with type 2 diabetes. The duration of these trials spanned from the establishment of the database to January 10, 2024. The obtained data were subjected to meta-analysis using Stata15.1 software. A total of 15 articles were included, encompassing 722 patients. RESULTS: The meta-analysis results showed that compared to the control group, green tea intervention significantly improved the improvement of fasting blood glucose (SMD = -0.41, 95% CI: -0.67 to -0.19, P = .001), glycated hemoglobin (SMD = -0.68, 95% CI: -1.15 to 0.21, P = .004) and insulin resistance index (SMD = -0.70, 95% CI: -1.18 to -0.22, P = .005) in the experimental group compared to the control group. The differences were statistically significant (P < .05). CONCLUSION: Green tea significantly improves fasting blood glucose, glycated hemoglobin and insulin resistance in patients with type 2 diabetes.
Key Findings
The meta-analysis results showed that compared to the control group, green tea intervention significantly improved the improvement of fasting blood glucose (SMD = -0.41, 95% CI: -0.67 to -0.19, P = .001), glycated hemoglobin (SMD = -0.68, 95% CI: -1.15 to 0.21, P = .004) and insulin resistance index (SMD = -0.70, 95% CI: -1.18 to -0.22, P = .005) in the experimental group compared to the control group. The differences were statistically significant (P < .05).
Outcomes Measured
- Requires manual extraction
Population
| Field | Value |
|---|---|
| Population | type 2 diabetes |
| Sample Size | 722 |
| Age Range | See abstract |
| Condition | diabetes |
MeSH Terms
- Humans
- Blood Glucose
- Diabetes Mellitus, Type 2
- Glycated Hemoglobin
- Insulin Resistance
- Randomized Controlled Trials as Topic
- Tea
Evidence Classification
- Level: Meta Analysis
- Publication Types: Journal Article, Meta-Analysis
- Vertical: green-tea-metabolic
Provenance
- PMID: 39809182
- DOI: 10.1097/MD.0000000000039702
- PMCID: PMC11596636
- Verified: 2026-04-09 via PubMed E-utilities API
Source extracted via PubMed E-utilities API on 2026-04-09